Royal Oak, MI, United States of America

James M Onoda

This inventor holds 1 USPTO granted patent. Top assignee: Wayne State University. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Tumor Treatment by James M Onoda

Introduction

James M Onoda is an accomplished inventor based in Royal Oak, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent. His work focuses on developing methods for treating malignant tumors, showcasing his dedication to advancing medical science.

Latest Patents

James M Onoda holds a patent for a method and composition for the treatment of tumors. This patent describes a method for the treatment of malignant tumors by co-administering a platinum coordination compound and a dihydropyridine class calcium channel blocker compound. The compounds are administered over a period of several days in at least two separate dosages of each compound. This approach aims to produce regression of the tumor in vitro and in vivo, as well as inhibit metastasis of the tumor in vivo. He has 1 patent to his name.

Career Highlights

James M Onoda is affiliated with Wayne State University, where he continues to engage in research and development in the field of oncology. His work has the potential to impact the lives of many patients suffering from malignant tumors.

Collaborations

Throughout his career, James has collaborated with notable colleagues, including Kenneth V Honn and John D Taylor. These collaborations have likely contributed to the advancement of his research and the successful development of his patent.

Conclusion

James M Onoda's innovative approach to tumor treatment exemplifies the importance of research and collaboration in the medical field. His contributions are paving the way for new therapeutic strategies in oncology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…